D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 51 Citations 9,742 84 World Ranking 12576 National Ranking 5353

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • RNA

His main research concerns Molecular biology, Genetics, APOBEC3G, APOBEC-3G Deaminase and Virology. His study in Molecular biology is interdisciplinary in nature, drawing from both Nuclear export signal, Cell nucleus, Protein subunit and Nuclear protein. His research investigates the connection between Cell nucleus and topics such as Ran that intersect with issues in RNA.

Genetics is closely attributed to Cell biology in his work. In his study, Tropism, Simian immunodeficiency virus and Cytidine deamination is strongly linked to Infectivity, which falls under the umbrella field of APOBEC3G. The Viral replication, Hepatitis B virus and Hepatitis B research he does as part of his general Virology study is frequently linked to other disciplines of science, such as Hepatitis B virus PRE beta and cccDNA, therefore creating a link between diverse domains of science.

His most cited work include:

  • A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins (438 citations)
  • Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. (334 citations)
  • Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. (325 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in RNA, Molecular biology, Cell biology, Genetics and Virology. The various areas that Hal P. Bogerd examines in his RNA study include Response element, Messenger RNA and In vitro. His Molecular biology study integrates concerns from other disciplines, such as Transcription, Long terminal repeat, Transcription factor, Peptide sequence and RNA silencing.

His research in Cell biology intersects with topics in DNA, Gene expression, Viral replication and DNA-binding protein. In the field of Genetics, his study on Mutant, Mutation, CRISPR and Human endogenous retrovirus K overlaps with subjects such as Retrotransposon. His Nuclear export signal research includes themes of Ran, Nuclear protein, Nucleoporin and RNA-binding protein.

He most often published in these fields:

  • RNA (38.37%)
  • Molecular biology (36.05%)
  • Cell biology (33.72%)

What were the highlights of his more recent work (between 2016-2021)?

  • RNA (38.37%)
  • Cell biology (33.72%)
  • Viral replication (17.44%)

In recent papers he was focusing on the following fields of study:

Hal P. Bogerd mainly focuses on RNA, Cell biology, Viral replication, Messenger RNA and Transactivation. His RNA study is concerned with the larger field of Biochemistry. His Cell biology research incorporates themes from Methylation, DNA, Gene expression, Retrovirus and Alternative splicing.

His DNA study is focused on Genetics in general. He works mostly in the field of Messenger RNA, limiting it down to topics relating to RNA virus and, in certain cases, Infectivity, microRNA, MiRNA binding, Influenza A virus and Post-transcriptional regulation. In his research on the topic of Transactivation, In vitro is strongly related with Response element.

Between 2016 and 2021, his most popular works were:

  • Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication (75 citations)
  • Epitranscriptomic Addition of m5C to HIV-1 Transcripts Regulates Viral Gene Expression. (47 citations)
  • Extensive Epitranscriptomic Methylation of A and C Residues on Murine Leukemia Virus Transcripts Enhances Viral Gene Expression. (22 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • RNA

Hal P. Bogerd spends much of his time researching Messenger RNA, RNA, Viral replication, Cell biology and RNA splicing. The various areas that he examines in his Messenger RNA study include RNA virus, Ribosome and Influenza A virus. His RNA virus study integrates concerns from other disciplines, such as Infectivity, MiRNA binding, microRNA and Post-transcriptional regulation.

Hal P. Bogerd has researched Viral replication in several fields, including Retrovirus, RNA editing, Downregulation and upregulation, Murine leukemia virus and Silent mutation. His research in Cell biology intersects with topics in Methylation and Mutant. Hal P. Bogerd has included themes like Gene expression, Virology, Hemagglutinin, Regulator and Methyltransferase in his RNA splicing study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins

Heather L Wiegand;Brian P Doehle;Hal P Bogerd;Bryan R Cullen;Bryan R Cullen.
The EMBO Journal (2004)

551 Citations

Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay.

H P Bogerd;R A Fridell;R E Benson;J Hua.
Molecular and Cellular Biology (1996)

428 Citations

Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

Hal P. Bogerd;Heather L. Wiegand;Amy E. Hulme;José L. Garcia-Perez.
Proceedings of the National Academy of Sciences of the United States of America (2006)

412 Citations

Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins

Hal P Bogerd;Robert A Fridell;Steven Madore;Bryan R Cullen.
Cell (1995)

381 Citations

A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor

Hal P. Bogerd;Brian P. Doehle;Heather L. Wiegand;Bryan R. Cullen.
Proceedings of the National Academy of Sciences of the United States of America (2004)

373 Citations

The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.

Dean W. Ballard;Eric P. Dixon;Nancy J. Peffer;Hal Bogerd.
Proceedings of the National Academy of Sciences of the United States of America (1992)

332 Citations

Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat.

Paul D. Bieniasz;Therese A. Grdina;Hal P. Bogerd;Bryan R. Cullen.
The EMBO Journal (1998)

328 Citations

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

Hal P. Bogerd;Heather L. Wiegand;Brian P. Doehle;Kira K. Lueders.
Nucleic Acids Research (2006)

301 Citations

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.

Alexandra Schäfer;Hal P. Bogerd;Bryan R. Cullen.
Virology (2004)

280 Citations

Inhibition of Human Immunodeficiency Virus Rev and Human T-Cell Leukemia Virus Rex Function, but Not Mason-Pfizer Monkey Virus Constitutive Transport Element Activity, by a Mutant Human Nucleoporin Targeted to Crm1

Hal P. Bogerd;Asier Echarri;Ted M. Ross;Bryan R. Cullen;Bryan R. Cullen.
Journal of Virology (1998)

237 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hal P. Bogerd

Bryan R. Cullen

Bryan R. Cullen

Duke University

Publications: 71

Reuben S. Harris

Reuben S. Harris

The University of Texas Health Science Center at San Antonio

Publications: 67

Paul D. Bieniasz

Paul D. Bieniasz

Rockefeller University

Publications: 43

Warner C. Greene

Warner C. Greene

University of California, San Francisco

Publications: 40

Michael H. Malim

Michael H. Malim

King's College London

Publications: 39

Xiao Fang Yu

Xiao Fang Yu

Zhejiang University

Publications: 35

Simon Wain-Hobson

Simon Wain-Hobson

Institut Pasteur

Publications: 31

Vinay K. Pathak

Vinay K. Pathak

National Institutes of Health

Publications: 31

Fatah Kashanchi

Fatah Kashanchi

George Mason University

Publications: 27

B. Matija Peterlin

B. Matija Peterlin

University of California, San Francisco

Publications: 26

Michael Emerman

Michael Emerman

Fred Hutchinson Cancer Research Center

Publications: 26

Klaus Strebel

Klaus Strebel

National Institutes of Health

Publications: 25

Chuan He

Chuan He

University of Chicago

Publications: 24

Ben Berkhout

Ben Berkhout

University of Amsterdam

Publications: 22

Marie-Louise Hammarskjold

Marie-Louise Hammarskjold

University of Virginia

Publications: 20

Jose L. Garcia-Perez

Jose L. Garcia-Perez

University of Granada

Publications: 19

Trending Scientists

David Brooks

David Brooks

Harvard University

Wu-chun Feng

Wu-chun Feng

Virginia Tech

Frank Seide

Frank Seide

Microsoft (United States)

Pavel Ginzburg

Pavel Ginzburg

Tel Aviv University

Mohini Sain

Mohini Sain

University of Toronto

J.E. Moxley

J.E. Moxley

McGill University

Igor Jurisica

Igor Jurisica

University Health Network

Pierre Abad

Pierre Abad

INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement

Eric J. Kremer

Eric J. Kremer

University of Montpellier

Erik Fransen

Erik Fransen

University of Antwerp

Anders Svensson

Anders Svensson

University of Copenhagen

Yijun Liu

Yijun Liu

University of Florida

Raymond Dingledine

Raymond Dingledine

Emory University

Nellie Georgiou-Karistianis

Nellie Georgiou-Karistianis

Monash University

Christopher McCarty

Christopher McCarty

University of Florida

Roy W. Chantrell

Roy W. Chantrell

University of York

Something went wrong. Please try again later.